Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » ASTM - BUY on dips- big play » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
CHGinc  - posted
we are in heavy on ASTM avg 0.635
 
T e x  - posted
again, who is "we" ?
 
CHGinc  - posted
TEX

you got mail
 
T e x  - posted
& you got a reply [Wink]
 
CHGinc  - posted
Aastrom Biosciences, Inc. operates as a regenerative medicine company, focusing on the clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell (TRC) technology. The company's TRC technology is based on its cell products, which are a unique cell mixture containing large numbers of stem and progenitor cells, produced outside of the body from a small amount of bone marrow taken from the patient, and the means to produce these products in an automated process. Its TRC-based products are being clinically evaluated for bone regeneration to treat osteonecrosis of the femoral head, which is in ON-CORE Phase III trial in the United States and in pivotal trial in Spain; and vascular regeneration in patients with critical limb ischemia that is in RESTORE-CLI Phase IIb trial in the United States and in Phase I/II trial in Germany. In addition, Aastrom Biosciences has completed a U.S. Phase I/II severe non-union fracture clinical trial, and is also developing programs to address cardiac and neural regeneration indications. TRC-based products have received Orphan Drug Designation from the Food and Drug Administration for use in the treatment of osteonecrosis of the femoral head and the treatment of dilated cardiomyopathy, a severe chronic heart disease. Aastrom Biosciences was founded in 1989 and is headquartered in Ann Arbor, Michigan.

Web Site: http://www.aastrom.com
 
PCola77  - posted
*In my mom's best teacher voice* No passing notes, please pass the note up here so I can read it in front of the class

[Smile]
 
CHGinc  - posted
http://www.windchart.com/stockta/analysis/?symbol=astm
 
invester  - posted
quote:
Originally posted by PCola77:
*In my mom's best teacher voice* No passing notes, please pass the note up here so I can read it in front of the class

[Smile]

LoL
 
SuperSniper00  - posted
yeah who is "we"?
 
SuperSniper00  - posted
Anytime someone says "we" and buy on dips, makes it sound to me like they want us to buy their shares while they sell.
 
CHGinc  - posted
So you think I want to sell you my shares when it dips? There is plenty of shares to go around or you can buy mine when it "spikes" lol

quote:
Originally posted by SuperSniper00:
Anytime someone says "we" and buy on dips, makes it sound to me like they want us to buy their shares while they sell.


 
Peaser  - posted
I'd rather buy STEM.
 
invester  - posted
ACTC is the MUCH beter play
 
AJGrano  - posted
In ACTC for .038, but only for like 5k shares. Lets see how that goes...
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share